Tarsus Pharmaceuticals (TARS) Stock Chart & Stock Price History $50.30 -1.61 (-3.10%) Closing price 04:00 PM EasternExtended Trading$50.12 -0.18 (-0.36%) As of 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tarsus Pharmaceuticals Stock Price Performance 5 Day Performance+3.82%1 Month Performance+6.11%3 Month Performance-3.44%6 Month Performance+9.75%Year-To-Date Performance-6.25%1 Year Performance+59.77% Receive TARS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address TARS Stock Chart for Thursday, May, 1, 2025 TARS Chart by TradingView Tarsus Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/30/2025$50.90$51.91+1.98%$52.10$49.70598,277 shs$1.99 billion04/29/2025$49.72$50.90+2.37%$51.24$49.031.34 million shs$1.95 billion04/28/2025$50.00$49.72-0.56%$50.50$47.97685,350 shs$1.91 billion04/25/2025$49.97$50.00+0.06%$50.38$48.98754,503 shs$1.92 billion04/24/2025$50.00$49.97-0.06%$50.50$48.72485,074 shs$1.92 billion04/23/2025$49.44$50.00+1.13%$51.00$49.50745,596 shs$1.92 billion04/22/2025$48.51$49.44+1.92%$49.77$48.35720,836 shs$1.90 billion04/21/2025$49.25$48.51-1.50%$49.36$47.76551,535 shs$1.86 billion04/18/2025$49.25$49.25$50.30$48.69364,974 shs$1.89 billion04/17/2025$49.39$49.25-0.28%$50.30$48.69364,974 shs$1.89 billion Get the Latest News and Ratings for TARS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/16/2025$49.12$49.39+0.55%$49.46$46.94403,603 shs$1.90 billion04/15/2025$48.72$49.12+0.82%$49.80$48.29369,827 shs$1.89 billion04/14/2025$46.43$48.72+4.93%$48.73$45.91395,810 shs$1.87 billion04/11/2025$44.12$46.43+5.24%$46.59$42.90781,138 shs$1.78 billion04/10/2025$45.87$44.12-3.82%$44.87$41.78773,979 shs$1.69 billion04/09/2025$44.63$45.87+2.78%$46.31$40.381.20 million shs$1.76 billion04/09/2025$44.63$45.87+2.78%$46.31$40.381.20 million shs$1.76 billion04/08/2025$47.49$44.63-6.02%$49.01$43.51686,600 shs$1.71 billion04/08/2025$47.49$44.63-6.02%$49.01$43.51686,600 shs$1.71 billion04/07/2025$47.02$47.49+1.00%$49.04$43.32907,593 shs$1.82 billion04/04/2025$49.55$47.02-5.11%$48.80$45.86677,880 shs$1.80 billion04/03/2025$51.49$49.55-3.77%$52.10$47.71524,648 shs$1.90 billion04/02/2025$48.92$51.49+5.25%$51.85$48.33598,049 shs$1.98 billion04/01/2025$51.37$48.92-4.77%$51.33$48.70688,400 shs$1.88 billion03/31/2025$51.74$51.37-0.72%$51.63$47.88663,864 shs$1.97 billion Related Companies Lantheus Stock Price Chart BridgeBio Pharma Stock Price Chart TG Therapeutics Stock Price Chart Legend Biotech Stock Price Chart Sarepta Therapeutics Stock Price Chart Telix Pharmaceuticals Limited American Depositary Shares Stock Price Chart ADMA Biologics Stock Price Chart Blueprint Medicines Stock Price Chart Verona Pharma Stock Price Chart Nuvalent Stock Price Chart Receive TARS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TARS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tarsus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TARS Stock Free TARS Stock Alerts